State of New Jersey Common Pension Fund D increased its holdings in Envista Holdings Co. (NYSE:NVST – Free Report) by 5.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,686 shares of the company’s stock after purchasing an additional 5,497 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.06% of Envista worth $2,128,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of NVST. Covestor Ltd increased its position in shares of Envista by 34.2% during the 3rd quarter. Covestor Ltd now owns 6,359 shares of the company’s stock valued at $125,000 after purchasing an additional 1,621 shares during the last quarter. Assetmark Inc. boosted its stake in Envista by 5.9% during the third quarter. Assetmark Inc. now owns 38,641 shares of the company’s stock worth $764,000 after buying an additional 2,152 shares during the period. Harbor Capital Advisors Inc. increased its position in Envista by 138.5% during the third quarter. Harbor Capital Advisors Inc. now owns 404,589 shares of the company’s stock valued at $7,995,000 after acquiring an additional 234,941 shares during the last quarter. US Bancorp DE raised its stake in shares of Envista by 150.6% in the third quarter. US Bancorp DE now owns 4,971 shares of the company’s stock valued at $98,000 after acquiring an additional 2,987 shares during the period. Finally, Hedges Asset Management LLC lifted its stake in Envista by 46.3% in the third quarter. Hedges Asset Management LLC now owns 46,800 shares of the company’s stock worth $925,000 after purchasing an additional 14,800 shares during the last quarter.
Envista Trading Down 1.3 %
Shares of NVST opened at $20.08 on Friday. The firm has a 50-day moving average price of $19.09 and a 200 day moving average price of $18.12. The firm has a market capitalization of $3.46 billion, a P/E ratio of -2.58, a P/E/G ratio of 2.86 and a beta of 1.30. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $25.64.
Analysts Set New Price Targets
NVST has been the topic of a number of analyst reports. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Evercore ISI lifted their target price on Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. JPMorgan Chase & Co. downgraded shares of Envista from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $23.00 to $16.00 in a research note on Thursday, August 8th. Piper Sandler boosted their price target on Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Finally, Wells Fargo & Company started coverage on shares of Envista in a research note on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $20.71.
View Our Latest Stock Analysis on NVST
Envista Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- Top Stocks Investing in 5G Technology
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Find and Profitably Trade Stocks at 52-Week Lows
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.